| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/06/2008 | EP1478777B1 Genetic marker for diffentiating mycobacteria |
| 08/06/2008 | EP1455824B1 Lyophilized preparation containing antibodies to the egf receptor |
| 08/06/2008 | EP1379670B1 Activated dual specificity lymphocytes and their methods of use |
| 08/06/2008 | EP1350521B1 Immunotherapeutic combinations for the treatment of tumors |
| 08/06/2008 | EP1257298B1 Cosmid dna constructs and methods of making and using the same |
| 08/06/2008 | EP1237575B1 Tnf-alpha antagonist and lfa-1 antagonist for treating rheumatoid arthritis |
| 08/06/2008 | EP1214410B1 Chimaeric plant viruses with mucin peptides |
| 08/06/2008 | EP1163002B1 Polycationic carbohydrates as immunostimulants in vaccines |
| 08/06/2008 | EP1157042B1 Production of tetravalent antibodies |
| 08/06/2008 | EP1127168B1 Method for determining the susceptibility to developing sepsis and therapeutics for the treatment of sepsis |
| 08/06/2008 | EP1108034B1 Attenuated salmonella spi2 mutants as antigen carriers |
| 08/06/2008 | EP0941241B1 Bordetella strain expressing the fha hybrid, |
| 08/06/2008 | EP0832109B1 Fibroblast growth factor homologous factor-2 and methods of use |
| 08/06/2008 | EP0666911B9 Multidrug resistance gene |
| 08/06/2008 | CN101238209A 登革血清型2减毒株 Save dengue serotype 2 strain |
| 08/06/2008 | CN101238150A Recombinant method for the production of a monoclonal antibody to CD52 for the treatment of chronic lymphocytic leukemia |
| 08/06/2008 | CN101238149A Novel anti-IGF-IR antibodies and uses thereof |
| 08/06/2008 | CN101238148A Method of producing antibodies with modified fucosylation level |
| 08/06/2008 | CN101238146A Immunogenic compositions for chlamydia trachomatis |
| 08/06/2008 | CN101237890A Stabilizer for protein preparation comprising meglumine and use thereof |
| 08/06/2008 | CN101237884A Int6 protein involved in hypoxia stress induction and use thereof |
| 08/06/2008 | CN101237882A Humanized anti-CD40 antibodies and their methods of use |
| 08/06/2008 | CN101237881A Immunoconjugate formulations |
| 08/06/2008 | CN101237879A 抗凝剂及其用途 Anticoagulants and their use |
| 08/06/2008 | CN101235364A Newcastle disease virus D90 strain and application thereof |
| 08/06/2008 | CN101235363A Pig transmissible gastroenteritis virus vaccine strain and application thereof |
| 08/06/2008 | CN101235089A Anti-beta2GPI gene engineering Fab antibody |
| 08/06/2008 | CN101235086A Recombination human rabies viruses resisting antibody |
| 08/06/2008 | CN101235083A HIV-I resisting polypeptide, coded sequence and use thereof |
| 08/06/2008 | CN101234199A Hepatitis B and encephalitis B combined vaccine and preparation thereof |
| 08/06/2008 | CN101234198A Method of preparing pig replication and respiration syndrome deactivation concentrated vaccine í«SD1 strainí» |
| 08/06/2008 | CN101234197A Recombination attenuation salmonella typhimurium vector vaccine and preparation |
| 08/06/2008 | CN101234196A Coccidiosis recombination bacillus calmette-guerin vaccine and preparation |
| 08/06/2008 | CN101234098A Application of erianin in preparing medicaments for treating tumor |
| 08/06/2008 | CN101234089A Alkaline fibroblast growth factor liposome vaccine and preparation method and application thereof |
| 08/06/2008 | CN100408683C HLA-A24-restricted cancer antigen peptide |
| 08/06/2008 | CN100408682C MUC-1 antigen with reduced number of VNTR repeat units |
| 08/06/2008 | CN100408675C Avian embryo particulate biomass for the production of virus antigens |
| 08/06/2008 | CN100408595C SARS virus HLA-A2 limited epitope polypeptide and uses thereof |
| 08/06/2008 | CN100408098C Application polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of tumor and diabetes mellitus |
| 08/06/2008 | CN100408097C Double specific ERB-B antibody and its use in treating tumor |
| 08/06/2008 | CN100408096C Gastrin compositions and methods of use and preparation |
| 08/06/2008 | CN100408095C Multivalent DTP-POLID vaccines |
| 08/05/2008 | US7408050 Modified CpG oligodeoxynucleotide with improved immunoregulatory function |
| 08/05/2008 | US7408044 Carrier protein having an adjuvant effect |
| 08/05/2008 | US7408039 Induction of chimera mixture; anticancer agents, leukemia |
| 08/05/2008 | US7408037 Polypeptide that, when mixed with a peripheral blood-mononuclear cell culture and incubated, induces cytotoxic T lymphocytes that contain HLA-A2-restricted cytotoxic T lymphocytes; anti-cancer vaccine |
| 08/05/2008 | US7408028 Peptides, antibodies thereto, and their use in treatment of central nervous system, damage |
| 08/05/2008 | US7408027 Epitopes of the tau protein which are specifically occurring in a phosphorylated state in tau protein from Alzheimer paired helical filaments; for the generation of antibodies specifically detecting Alzheimer tau protein; for testing drugs effective in dissolving Alzheimer paired helical filaments |
| 08/05/2008 | US7407944 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends |
| 08/05/2008 | US7407936 Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy |
| 08/05/2008 | US7407935 Ricin toxin A-chain fragment for use as a vaccine |
| 08/05/2008 | US7407807 Chimaeric human papillomavirus 16 I1 virus like particles and a method for preparing the particles |
| 08/05/2008 | US7407803 Immunogenic composition comprising bacterial or viral vector, antigen and toxins; escherichia and baculovirus; vaccines |
| 08/05/2008 | US7407802 Plasmid comprising nucleotide sequences coding vaccine specific to newcastle disease virus hemagglutinin-neuraminidase (HN) for use in prevention and treatment of viral diseases in plants |
| 08/05/2008 | US7407790 Recombinant double-stranded RNA phages and uses thereof |
| 08/05/2008 | US7407789 Polymerizing ability and cellular and humoral immunogenicity decreased as compared with the wild the wild-type staphylokinase; Mutant genes were constructed by PCR site-directed mutagenesis, then recombined with a prokaryotic vector and used to transform E. coli.; thrombolytics and anticoagulant |
| 08/05/2008 | US7407770 Which bind specifically to polypeptides; microtiter plate and enzyme linked immunosorbent assay; diagnosis and treatment of canine and human ehrlichiosis |
| 08/05/2008 | US7407752 Using triplex formation as a tool in prevention of viral gene expression; viricides |
| 08/05/2008 | US7407751 Methods for the detection and prognosis of breast tumors |
| 08/05/2008 | US7407664 Peptide vaccines against group A streptococci |
| 08/05/2008 | US7407663 Modified immunodeficiency virus particles |
| 08/05/2008 | US7407662 Modified virus comprising low cholesterol content for use as tool in preventing and treating viral infection; immunostimulants |
| 08/05/2008 | US7407661 Methods and reagents that generate a CD8 T cell immune response |
| 08/05/2008 | US7407659 Methods of diagnosing pre-eclampsia or eclampsia |
| 08/05/2008 | US7407658 polypeptide induces production of antibodies against protein on surface of zygotes to prevent infection of malaria from mosquito |
| 08/05/2008 | US7407657 Of given sequence; derived from Japanese cypress pollen allergen; stimulates lymphocytes; reduce symptoms of pollinosis; immunotherapy and diagnosis |
| 08/05/2008 | US7407656 PSCA: prostate stem cell antigen and uses thereof |
| 08/05/2008 | US7407655 Method of inhibiting leukocytes with human CXC chemokine receptor 3 antibody |
| 08/05/2008 | US7407653 Treatment of IgA1 deposition diseases |
| 08/05/2008 | CA2667965A1 Prophylactic tuberculosis vaccine |
| 08/05/2008 | CA2340888C Novel tumor antigen protein sart-3 and tumor antigen peptide thereof |
| 08/05/2008 | CA2290485C Method for the production of non-immunogenic proteins |
| 08/05/2008 | CA2273922C Novel saponin compositions and uses thereof |
| 08/05/2008 | CA2246715C Antibody variants |
| 08/05/2008 | CA2163989C Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
| 07/31/2008 | WO2008092084A2 Injectable non-aqueous suspension with high concentration of therapeutic agent |
| 07/31/2008 | WO2008092014A1 Methods and compositions for depleting specific cell populations from blood tissues |
| 07/31/2008 | WO2008091981A2 Monoclonal antibody that suppresses thyrotropin receptor constitutive activity |
| 07/31/2008 | WO2008091911A2 Use of antibody conjugates |
| 07/31/2008 | WO2008091908A2 Human cancer stem cells |
| 07/31/2008 | WO2008091781A1 Reducing tumor growth |
| 07/31/2008 | WO2008091701A2 Use of anti-egfr antibodies in treatment of egfr mutant mediated disease |
| 07/31/2008 | WO2008091659A2 Methods and compositions for predicting and treating drug resistant strains of influenza virus |
| 07/31/2008 | WO2008091643A2 Evaluating synergy of combinations comprising an antibody in immune suppressive pathways concurrent to immunotherapy |
| 07/31/2008 | WO2008091641A2 Compositions and methods for diagnosing and treating cancer |
| 07/31/2008 | WO2008091601A2 Methods and compositions for enhancing growth of fish and shellfish |
| 07/31/2008 | WO2008091416A2 Antibiotic antimicrobial agents and methods of their use |
| 07/31/2008 | WO2008091398A2 Jc virus vaccine |
| 07/31/2008 | WO2008091375A2 Attenuated salmonella as a delivery system for sirna-based tumor therapy |
| 07/31/2008 | WO2008091222A1 Dll4 signaling inhibitors and uses thereof |
| 07/31/2008 | WO2008090960A1 Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2 |
| 07/31/2008 | WO2008090959A1 Genetically recombinant antibody composition having enhanced effector activity |
| 07/31/2008 | WO2008090958A1 Domain-exchanged recombinant antibody composition |
| 07/31/2008 | WO2008090901A1 Chronic rejection inhibitor |
| 07/31/2008 | WO2008090850A1 Agent for enhancing the effect of anticancer agent |
| 07/31/2008 | WO2008090360A1 Methods |
| 07/31/2008 | WO2008090355A2 Inhibitors of stem cells markers |
| 07/31/2008 | WO2008090327A1 New combination for use in the treatment of cancer |
| 07/31/2008 | WO2008090319A2 Methods and biomarkers for diagnosing and monitoring psychotic disorders |